Results 221 to 230 of about 36,160 (268)
Some of the next articles are maybe not open access.
The pneumococcal conjugate vaccine.
Minerva pediatrica, 2003Streptococcus pneumoniae is the most frequent cause of otitis media, sinusitis, and pneumonia in children. It is also one of the most common causes of invasive bacterial infections in children including bacteremia and meningitis. One of the current issues regarding S. pneumoniae is the emergence of pneumococcal strains resistant to penicillin and other
R M, Jacobson, G A, Poland
openaire +1 more source
Designing spatial and temporal control of vaccine responses
Nature Reviews Materials, 2021Shih Hao Ou, Wei Luo, Bali Pulendran
exaly
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Nature Reviews Clinical Oncology, 2021Aakash Desai +2 more
exaly
SARS-CoV-2 variants, spike mutations and immune escape
Nature Reviews Microbiology, 2021William T Harvey +2 more
exaly
Pneumococcal conjugate vaccines
The Pediatric Infectious Disease Journal, 2000openaire +2 more sources
Pneumococcal disease and conjugate vaccines
Enfermedades Infecciosas y Microbiología Clínica, 2018Jordi, Càmara, Carmen, Ardanuy
openaire +2 more sources
Pneumococcal conjugate vaccine update.
The Journal of family practice, 2020ACIP no longer recommends routine use of PCV13 in immunocompetent adults ≥ 65 years. Three simple statements summarize guidance on intervals to follow when administering both PCV13 and PPSV23.
openaire +1 more source
Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation
Ca-A Cancer Journal for Clinicians, 2020Robert A Smith
exaly
Effectiveness of pneumococcal conjugate vaccine
The Lancet, 2006Katherine L, O'Brien, Orin S, Levine
openaire +2 more sources